Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound‑Guided Intra‑Articular Injection of Triamcinolone Extended‑Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open‑Label, Randomized Study

PRODUCT LITERATURE

Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound‑Guided Intra‑Articular Injection of Triamcinolone Extended‑Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open‑Label, Randomized Study

Hanson P - Personal Name;

Osteoarthritis (OA) is a major public health burden. While knee and hip joints are most com-
monly affected, the glenohumoral (shoulder) joint is also frequently involved. We evaluated the pharmacokinetics and safety/
tolerability of triamcinolone acetonide extended-release (TA-ER) and triamcinolone acetonide crystalline suspension (TAcs)
in patients with shoulder OA.

Availability

Location name is not set Location name is not set

FLAMICORT-013

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): FLAMICORT
Triamcinolone Acetonide
Shoulder Osteoarthritis
Specific Detail Info: Drugs in R&D (2021) 21:285–293
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment